What is the purpose of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial?
The purpose of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial was to investigate the risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome. It was a secondary analysis of the SPARCL trial and the results were published in Arch Neurol. 2011;68:1245 1251.